Article metrics

PDF

Extended report
A randomised phase IIb study of mavrilimumab, a novel GM–CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis

Statistics from Altmetric.com

Online download statistics by month:

Online download statistics by month: February 2017 to June 2019

AbstractFullPdf
Feb 201710174420
Mar 201711916405
Apr 20172438111
May 20170577205
Jun 201769302120
Jul 2017246247105
Aug 201720820984
Sep 2017211211101
Oct 201725625685
Nov 201724324352
Dec 201735035054
Jan 201839239375
Feb 201827926846
Mar 201831130553
Apr 201840941254
May 201820520647
Jun 201818819037
Jul 201815815845
Aug 201828028058
Sep 201818918954
Oct 201823523593
Nov 201825226162
Dec 201819019142
Jan 201920921148
Feb 201925425871
Mar 201916316357
Apr 201917017045
May 201914314048
Jun 201913713756
Total577080902733